510(k) Report

510(k) · Cleared

Cleared

VersaCross Connect™ Transseptal Dilator

K251325510(k) SpecialCleared May 29, 202530-day reviewClass II21 CFR 870.1310

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Baylis Medical Company, Inc. · DRE Dilator, Vessel, For Percutaneous Catheterization

Cleared on May 29, 2025 as substantially equivalent to K241720 (Baylis Medical Company, Inc., 2024) after a 30-day review. Its family tree reaches back 6 generations to 2002. 1 of the 7 devices in its family, counting itself, has a Class I recall.

Decided
May 29, 2025
Review
30 days
Class
Class II
Product code
DRE
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K013919 (2002). No later device cites it as a predicate yet. 1 of the 7 devices in this family, counting this one, has a Class I recall.

  1. Root · 6 generations backK013919 Torflex Transseptal Guiding SheathBaylis Medical Co., Inc. · 2002 · Recalled
  2. 5 generations backK102948 Torflex Transseptal Guiding SheathBaylis Medical Co., Inc. · 2011 · Recalled (Class I)
  3. 4 generations backK182064 ExpanSure Transseptal Dilation SystemBaylis Medical Company, Inc. · 2019
  4. 3 generations backK201288 ExpanSure Large Access Transseptal DilatorBaylis Medical Company, Inc. · 2020
  5. 2 generations backK220414 VersaCross Connect Transseptal DilatorBaylis Medical Company, Inc. · 2022
  6. 1 generation backK241720 VersaCross Connect™ Transseptal DilatorBaylis Medical Company, Inc. · 2024
  7. This deviceK251325 VersaCross Connect™ Transseptal DilatorBaylis Medical Company, Inc. · 2025

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K013919Torflex Transseptal Guiding SheathBaylis Medical Co., Inc.20021
−5K102948Torflex Transseptal Guiding SheathBaylis Medical Co., Inc.2011Class I
−4K182064ExpanSure Transseptal Dilation SystemBaylis Medical Company, Inc.2019—
−3K201288ExpanSure Large Access Transseptal DilatorBaylis Medical Company, Inc.2020—
−2K220414VersaCross Connect Transseptal DilatorBaylis Medical Company, Inc.2022—
−1K241720VersaCross Connect™ Transseptal DilatorBaylis Medical Company, Inc.2024—
0 (this device)K251325VersaCross Connect™ Transseptal DilatorBaylis Medical Company, Inc.2025—
FIG. 1 — Lineage of K251325, 2002–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DRE device

  1. #1 K261310 FlexTract Deflectable-Rotational Dilator…score 12.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K241720VersaCross Connect™ Transseptal Dilator
Summary page 6
…saCross Transseptal Dilator is indicated Connect™ Baylis Medical K241720 for use in procedures where Transseptal Company Inc. access to the l…
Baylis Medical Company, Inc.2024—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K102948Torflex Transseptal Guiding SheathBaylis Medical Co., Inc. · 2011 · 5 generations back · ◆ on the line of descent in FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 23 years and passes through 2 companies; a new generation was cleared every 2.2 years on median.
  • 2 of the 6 ancestors have a recall of any class; 1 has a Class I recall.

How does its category compare?

All DRE devices

DRE Dilator, Vessel, For Percutaneous Catheterization: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · DRE

3in 2025

2007: 52008: 22009: 22010: 12011: 12012: 12013: 42014: 62015: 42016: 32017: 42018: 22019: 32020: 32021: 12022: 32023: 22024: 12025: 32026 (partial year): 1
2007high 6 (2014) · low 1 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DRE

31in 2025

2007: 160 days median2013: 111 days median2014: 72 days median2015: 30 days median2016: 90 days median2017: 108 days median2019: 68 days median2020: 30 days median2022: 261 days median2025: 31 days median
2007high 261 (2022) · low 30 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DRE

1in 2016

2009: 22010: 22011: 12015: 12016: 12026 (partial year): 1, 1 Class I
2007high 2 (2009) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · DRE

356in 2025

2007: 812008: 382009: 692010: 732011: 902012: 1322013: 1202014: 822015: 822016: 842017: 1012018: 1262019: 1442020: 1202021: 1152022: 1362023: 3862024: 3252025: 356
2007high 386 (2023) · low 38 (2008)2025

MAUDE reports naming product code DRE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20075160081
20082—038
20092—269
20101—273
20111—190
20121—0132
201341110120
2014672082
2015430182
2016390184
201741080101
20182—0126
20193680144
20203300120
20211—0115
202232610136
20232—0386
20241—0325
20253310356
20261—1 (1)—

What is it indicated for?

The VersaCross Connect Transseptal Dilator is indicated for use in procedures where access to the left atrium via the transseptal technique is desired.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K251325: VersaCross Connect™ Transseptal Dilator.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K251325

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026